Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT03039881 Completed - Clinical trials for Monitoring for Low Minute Ventilation Post Surgery

Evaluation of Non-Invasive Respiratory Volume Monitor

Start date: January 9, 2015
Phase:
Study type: Observational

This observational study investigates the validity and utility of a new, non-significant risk, FDA approved respiratory monitor, ExSpiron, in the perioperative course of patients undergoing elective surgery under general anesthesia. The study patients will be monitored before, during and after surgery, in post-anaesthesia care unit (PACU) and recovery room for the first post-operative night. The physiologic data will not be used or influence the standard of care for subjects. It is anticipated that this monitor may be able to improve perioperative care in the future.

NCT ID: NCT03039621 Completed - Clinical trials for Acute Respiratory Viral Infections

Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Acute Respiratory Viral Infections in Children

Start date: October 7, 2016
Phase: Phase 4
Study type: Interventional

The international multicenter double-blind placebo-controlled randomized clinical study in parallel groups.The objective of this study is to obtain additional data on the efficacy and safety of Ergoferon in the treatment of acute respiratory viral infections (ARVI) in children aged from 6 months to 6 years old.

NCT ID: NCT03039478 Completed - Clinical trials for Physiological Satiation Mechanisms

Effect of Different Concentrations of Xylitol and Erythritol on Gut Peptide Release and Gastric Emptying in Humans

Start date: February 24, 2017
Phase: N/A
Study type: Interventional

Xylitol and erythritol have become increasingly popular as sugar substitutes in the food industry. Both substances are freely available. While glucose ingestion stimulates satiation hormone secretion in the gut and slows down gastric emptying, artificial sweeteners such as aspartame, sucralose and acesulfame-K have no such effect. However, acute intake of 50g xylitol or 75g erythritol in 300mL tap water leads to a marked increase in the satiation hormones and induces a significant retardation in gastric emptying. The concentrations used to Show this effect were rather high (50g xylitol and 75g erythritol) and led to bloating and diarrhea in 60-70% of all subjects two hours after administration. The aim of the present study is to find an effective concentration of xylitol and erythritol still stimulating satiation hormone release without any gastrointestinal adverse events.

NCT ID: NCT03039322 Completed - Clinical trials for Screening for Hepatocellular Carcinoma

Golgi Protein for HCC Diagnosis

Start date: December 22, 2014
Phase: N/A
Study type: Observational

This case-control study was conducted on 90 patients who were equally divided into two groups. Group 1 included 45 patients with HCV-related chronic liver disease without clinical or radiological evidence of HCC (control group), and Group 2 included 45 patients diagnosed to have HCC by Triphasic abdominal CT (patient group). Serum AFP and GP73 were measured using ELISA technique

NCT ID: NCT03039257 Completed - Clinical trials for Hematopoietic Stem Cell Transplant

Vitamin A Replacement in Patients Undergoing HSCT and Its Role on MBI-LCBI Rates

Start date: February 2, 2017
Phase: N/A
Study type: Interventional

The primary objective of this study is to establish that single dose vitamin A supplementation is feasible and safe in pediatric and young adult bone marrow transplant recipients until day +30 (± 7 days) after hematopoietic stem cell transplantation.

NCT ID: NCT03038893 Completed - Clinical trials for Deep Venous Thromboses

Point of Care Ultrasound For The Diagnosis Of Deep Venous Thrombosis And Its Effect On Length Of Hospital Stay

Start date: August 1, 2016
Phase: N/A
Study type: Interventional

This is a Clinical Trial on the use of Point Of Care Ultrasound for the diagnosis of deep venous thrombosis (DVT) and its effect on length of hospital stay. 25 participants with suspicion of DVT according to Wells Criteria were randomized to one of two groups: Point of Care Ultrasound and Echo Doppler Ultrasound (POCUS + EDUS), and the control group was submitted only to the Echo Doppler Ultrasound (EDUS). The primary outcome was hospital stay.

NCT ID: NCT03038880 Completed - Clinical trials for Macular Degeneration, Age-Related

Study to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular Degeneration

STAIRWAY
Start date: January 27, 2017
Phase: Phase 2
Study type: Interventional

This was a Phase II, multicenter, randomized, active comparator-controlled, 52-week study to investigate the efficacy, safety and pharmacokinetics of faricimab (RO6867461; RG7716) administered with extended dosing regimens in treatment-naive participants with neovascular age related macular degeneration (nAMD). Only one eye was chosen as the study eye.

NCT ID: NCT03038815 Completed - Clinical trials for Rehabilitation After Ankle Injuries

The Influence of Stability Boots on Gait Pattern in Healthy Adults

Start date: February 1, 2017
Phase: N/A
Study type: Interventional

After an ankle injury like distorsions, fractures or arthrodeses, or congenital defects ankle support limit the range of motion in the joint, help pain relief, control loading of the injured tissues and promote recovery of a normal gait pattern. Gait analysis is applied in orthopedics, sport science and rehabilitation. Numerous measure systems and methods enable accurate analysis of human movement. The study is set to describe and compare the gait analysis of two modifiable stability boots (Ortho® Tri-Phase and the VACOped®) on the standard walking parameters during two conditions (level and ramp walking) in healthy adults and draw comparisons with a control indoor shoe.

NCT ID: NCT03038789 Completed - Clinical trials for Adult Patients With Type 2 Diabetes Mellitus

XIGDUO Extended Release (XR) Post Marketing Surveillance

XigduoPMS
Start date: April 20, 2017
Phase:
Study type: Observational

This is a local, prospective, non-interventional, regulatory postmarketing surveillance study. Adult patients with type 2 diabetes mellitus who are initiating Xigduo XR as indicated by the Ministry of Food and Drug Safety (MFDS) will be included.

NCT ID: NCT03038607 Completed - Clinical trials for Intrauterine Growth Restriction Asymmetrical

Aspirin in Asymmetrically Intrauterine Growth

Start date: January 2016
Phase: Phase 2
Study type: Interventional

Intrauterine growth restriction refers to a fetus that has failed to get a specific measures by a gestational age. Asymmetric type of Intrauterine growth restriction is known by normal sized head with smaller abdomen.It is important to recognize the growth restricted fetuses, because these fetuses may have fetal or neonatal complications. When blood flow is increased, the oxygen and nutrients will deliver good to the fetus. The role of low-dose aspirin therapy in management of intrauterine growth restriction is controversial. It has been used, in many studies, in prevention of intrauterine growth restriction especially in women at high risk of pre-eclampsia or obstetrical antiphospholipid syndrome.